Steminent Biotherapeutics Inc. (TPEX:7729)
Taiwan · Delayed Price · Currency is TWD 77.90
+1.10 (1.43%)
Sep 8, 2026, 12:12 PM CST
Steminent Biotherapeutics Market Cap
Steminent Biotherapeutics has a market cap or net worth of 6.19 billion as of September 4, 2026. Its market cap has increased by 143.17% in one year.
Market Cap
6.19B
Enterprise Value
5.37B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
77.90
ChartMarket Cap Chart
Since March 11, 2024, Steminent Biotherapeutics's market cap has increased from 2.24B to 6.19B, an increase of 176.25%. That is a compound annual growth rate of 50.25%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 8, 2026 | 6.19B | 54.53% |
| Dec 31, 2025 | 4.00B | 211.83% |
| Dec 31, 2024 | 1.28B | -42.67% |
| Mar 11, 2024 | 2.24B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Locus Cell | 8.09B |
| TWi Biotechnology | 7.79B |
| Adimmune | 7.40B |
| Acepodia | 7.05B |
| Savior Lifetec | 6.35B |
| TaiGen Biopharmaceuticals Holdings | 6.23B |
| Sinphar Pharmaceutical | 6.17B |
| AnnJi Pharmaceutical | 5.82B |